mbcc 2017: it’s too early to give up on immunotherapy for breast cancer
Published 7 years ago • 31 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
3:53
mbcc 2017: multiple parp inhibitors show promise in breast cancer treatment
-
2:54
panacea trial and implications for pembrolizumab use in breast cancer
-
2:27
can allergy shots cut asthma risk?
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
2:07
triple-negative breast cancer and brca mutations
-
1:16:59
breast cancer & immunotherapy
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
8:24
understanding breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
0:15
activated t cell attacks a cancer cell
-
3:17
multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
-
15:34
immunotherapy" conquering cancer from the inside | arthur brodsky | tedxwilmingtonsalon
-
46:20
immunotherapy for breast and pancreatic cancers, with elizabeth jaffee
-
34:50
breast cancer immunotherapy with dr. sylvia adams and victor ty, bsn, rn
-
2:08
immunotherapy is breaking barriers for breast cancer treatment
-
0:59
immunotherapy for cancer treatment
-
5:50
immunotherapy and breast cancer: how does it work?
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
6:06
immunotherapy in breast cancer